0
Commentary |

Garnering Support for Advance Care Planning

Terri R. Fried, MD; Margaret Drickamer, MD
[+] Author Affiliations

Author Affiliations: Department of Medicine, Yale University School of Medicine, New Haven, Connecticut (Drs Fried and Drickamer); and Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven (Dr Fried).


JAMA. 2010;303(3):269-270. doi:10.1001/jama.2009.1956
Text Size: A A A
Published online

The recent transfiguration in the popular press of a proposal to provide Medicare reimbursement to physicians for advance care planning (ACP) into the creation of “death panels,” which would decide the fates of older and disabled individuals,1 can be seen as more than a political maneuver to discredit health care reform efforts. It provides valuable insights into how the notion of ACP is perceived by the general public and a lesson for the medical community about how to promote ACP.

As originally presented in America's Affordable Health Choices Act HR 3200, section 1233 entitled Advance Care Planning Consultation described reimbursement for a clinician visit in which a practitioner explained advance care planning, living wills, the role of a health care proxy, and orders regarding life-sustaining treatments.2 This section of the bill was distorted by many politicians and commentators into a mandate by which older and disabled individuals would be forced to forgo life-sustaining treatments. Advance care planning, widely viewed by the medical community as an underused means of improving end-of-life care by allowing patients to exert their fundamental right to self-determination over future events and to ensure that they receive care at the end of life consistent with their values, was thereby transformed into a means for the government to deny individuals the care they desire. How could this have happened?

The answer lies both in the history of and prevailing attitudes toward ACP. Although ACP had been a part of medical care and local legislation for a decade, it became a nationally sanctioned method by which individuals could forgo medical care with the Patient Self-Determination Act of 1990 and the Supreme Court decision Cruzan v Director, Missouri Department of Health in the same year.3 In the latter, the court affirmed the right for individuals to refuse unwanted therapies if they became incapable of making decisions. The Patient Self-Determination Act required that all agencies receiving Medicare or Medicaid funds ask all patients about the existence of advance planning documents and offer to help them complete such documents if desired.4 Thus, the focus of ACP became the documentation of directives regarding the care that individuals would not receive at the end of life.

Based on the recognition that seriously ill patients are at risk for receiving highly burdensome care with limited benefit, the medical community caring for seriously ill patients generally assumes there is a pent-up demand among individuals to participate in ACP and to put a limit on the technologically invasive care they will receive at the end of life. Undoubtedly, many individuals may want the opportunity to state their desire to forgo medical interventions in advanced illness. However, the recent media experience with America's Affordable Health Choices Act2 provided the opportunity for expressions of support for ACP. The fact that this support did not occur reflects what may be in part due to a pervasive concern in the general public—not that they will receive too much care but rather, that they will receive too little.

Although there has been little direct empirical study of the phenomenon, indirect evidence supports this assertion. Even patients with advanced illness often desire technologically aggressive and potentially burdensome care for illness exacerbations. One commentator attributed this willingness to undergo continued interventions to the “widespread and deeply held desire not to be dead.”5 Although individuals may want to limit their care under conditions when death is inevitable, medicine can rarely provide this level of prognostic certainty, and accustomed to hearing about the miracles of modern medicine, patients may worry that the physician will give up too soon.

Moreover, increasing evidence suggests that substantial proportions of patients may not want to plan for their end-of-life care, based on the beliefs in the need to take things one day at a time, the impossibility of being able to plan for the future, or the difficulty in contemplating serious illness and death.6 Underlying these attitudes is the societal phenomenon in modern western cultures of the denial of death,7 which is fueled by the ever-increasing ability of modern medicine to postpone the inevitable.

Advance care planning may best be considered a part of medical care similar to counseling about exercise, smoking cessation, dietary change, and cancer screening; ie, activities that are good for individuals but which they may not want. Unlike these behaviors, however, ACP may not even be recognized as something that patients should do.

How then can public support for ACP be garnered? It may be that demand for more and better ACP will not occur unless and until there is a broad societal change to accept death as a part of life and to demedicalize the dying process. It also may be possible to promote ACP with less sweeping change. Whereas opponents of the bill were able to convince the public that ACP restricted choice, proponents of ACP need to emphasize that ACP facilitates patient choice. This requires acknowledging the concerns of individuals who believe ACP is a mechanism for limiting care.8

Some evidence suggests that clinicians tend to engage patients and families in discussions about preferences for care only late in the course of illness9 and to ask about preferences only in the most dire of hypothetical scenarios.10 These practices suggest that clinicians frequently use ACP to encourage patients and families to make decisions to forgo care when the clinician believes the care would be inappropriate. In contrast, the promotion of ACP requires that clinicians be prepared to accept whatever option an individual chooses by including a consideration of all reasonable treatment alternatives. Clinicians and policy makers must be clear that ACP is not the means for addressing issues of futility or the high costs of end-of-life care.8

Just as with other preventive health care behaviors, the promotion of ACP also requires development of a message to the public. Although the process of personal participation in ACP should take place on the clinical level with an individualized interaction between patient and clinician, the process of encouraging participation in ACP must occur on the population level. Building on health behavior models, this effort requires increasing the public's awareness of ACP by providing accurate information about the benefits of engaging in ACP, the potential negative consequences of failing to engage, and strategies to overcome barriers to engagement. Delivering these messages will require broad outreach, such as through the use of public service announcements.

The prominent role of religious beliefs in shaping attitudes toward ACP also calls for outreach to religious institutions. The promotion of ACP may be most effective if it takes advantage of situations in which individuals overcome their reluctance to think about death and dying to engage in other forms of planning for the future. For example, information about ACP could be provided to individuals when they participate in estate or funeral planning. Convincing the public of the benefits of ACP as a process to promote choice will help generate widespread support and demand for this practice to be a reimbursable part of medical care.

AUTHOR INFORMATION

Corresponding Author: Terri R. Fried, MD, CERC 151B, VA Connecticut Healthcare System, 950 Campbell Ave, West Haven, CT 06516 (terri.fried@yale.edu).

Financial Disclosures: None reported.

Funding/Support: Dr Fried is supported by grant K24 AGAG028443 from the National Institute on Aging.

Role of the Sponsor: The National Institute on Aging had no role in the preparation, review, or approval of the manuscript.

Rutenberg J, Calmes J. Getting to the source of the “death panel” rumor. New York Times. August 14, 2009: sect A 1
 America's Affordable Health Choices Act of 2009 (Introduced in House), HR 3200, 111th Cong, 1st Sess (2009) 
 Cruzan v Director, Missouri Department of Health. 497 US 261 (1990) 
La Puma J, Orentlicher D, Moss RJ. Advance directives on admission: clinical implications and analysis of the Patient Self-Determination Act of 1990.  JAMA. 1991;266(3):402-405
PubMedCrossRef
Finucane TE. How gravely ill becomes dying: a key to end-of-life care.  JAMA. 1999;282(17):1670-1672
PubMedCrossRef
Fried TR, Bullock K, Iannone L, O'Leary JR. Understanding advance care planning as a process of health behavior change.  J Am Geriatr Soc. 2009;57(9):1547-1555
PubMedCrossRef
Zimmermann C, Rodin G. The denial of death thesis: sociological critique and implications for palliative care.  Palliat Med. 2004;18(2):121-128
PubMedCrossRef
Levinsky NG. The purpose of advance medical planning: autonomy for patients or limitation of care?  N Engl J Med. 1996;335(10):741-743
PubMedCrossRef
The SUPPORT Principal Investigators.  A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT).  JAMA. 1995;274(20):1591-1598
PubMedCrossRef
Tulsky JA, Fischer GS, Rose MR, Arnold RM. Opening the black box: how do physicians communicate about advance directives?  Ann Intern Med. 1998;129(6):441-449
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Rutenberg J, Calmes J. Getting to the source of the “death panel” rumor. New York Times. August 14, 2009: sect A 1
 America's Affordable Health Choices Act of 2009 (Introduced in House), HR 3200, 111th Cong, 1st Sess (2009) 
 Cruzan v Director, Missouri Department of Health. 497 US 261 (1990) 
La Puma J, Orentlicher D, Moss RJ. Advance directives on admission: clinical implications and analysis of the Patient Self-Determination Act of 1990.  JAMA. 1991;266(3):402-405
PubMedCrossRef
Finucane TE. How gravely ill becomes dying: a key to end-of-life care.  JAMA. 1999;282(17):1670-1672
PubMedCrossRef
Fried TR, Bullock K, Iannone L, O'Leary JR. Understanding advance care planning as a process of health behavior change.  J Am Geriatr Soc. 2009;57(9):1547-1555
PubMedCrossRef
Zimmermann C, Rodin G. The denial of death thesis: sociological critique and implications for palliative care.  Palliat Med. 2004;18(2):121-128
PubMedCrossRef
Levinsky NG. The purpose of advance medical planning: autonomy for patients or limitation of care?  N Engl J Med. 1996;335(10):741-743
PubMedCrossRef
The SUPPORT Principal Investigators.  A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT).  JAMA. 1995;274(20):1591-1598
PubMedCrossRef
Tulsky JA, Fischer GS, Rose MR, Arnold RM. Opening the black box: how do physicians communicate about advance directives?  Ann Intern Med. 1998;129(6):441-449
PubMed
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles